Fonar Corp. (FONR)
-NasdaqCM 6.28 
0.19(3.10%) 3:59PM EDT
| Prev Close: | 6.09 |
|---|
| Open: | 6.14 |
|---|
| Bid: | 6.01 x 2000 |
|---|
| Ask: | 6.95 x 300 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.32 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 6.14 - 6.29 |
|---|
| 52wk Range: | 3.02 - 7.94 |
|---|
| Volume: | 27,503 |
|---|
| Avg Vol (3m): | 53,375 |
|---|
| Market Cap: | 38.28M |
|---|
| P/E (ttm): | 7.57 |
|---|
| EPS (ttm): | 0.83 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- FONAR CORP FinancialsEDGAR Online Financials(Sat, Jun 1)
- FONAR CORP Files SEC form 8-K/A, Financial Statements and ExhibitsEDGAR Online(Mon, May 20)
- FONAR CORP Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Thu, May 16)
- FONAR CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- FONAR Announces Fiscal 2013 3rd Quarter and Nine Month Earnings Report; Total Assets Double; 3rd Quarter Revenues Increase 22% and 7th Straight Quarter of $1.5 Million of Net IncomeMarketwired(Wed, May 15)
- Fonar: A Company Ready For New Highs Again - Part 2at Seeking Alpha(Sun, May 12)
- Medical Symposium Organized by Fonar to Focus on The Cranio-Cervical Syndrome - The Vulnerability of the Human Neck and Its Impact on Cerebrospinal Fluid (CSF) FlowMarketwired(Mon, Apr 1)
- Medical Symposium Organized by Fonar to Focus on The Cranio-Cervical Syndrome - The Vulnerability of the Human Neck and Its Impact on Cerebrospinal Fluid (CSF) FlowMarketwired(Thu, Mar 28)
- FONAR CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and ExhibitsEDGAR Online(Mon, Mar 11)
- FONAR Corporation to resume trading at 12:15 pm ETtheflyonthewall.com(Wed, Mar 6)
- FONAR's Subsidiary Acquires Business Managing 12 UPRIGHT(R) MRI ScannersMarketwired(Wed, Mar 6)
- 4 Stocks Under $10 Spiking Higherat TheStreet(Fri, Feb 22)
- FONAR CORP Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Fri, Feb 15)
- FONAR CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Feb 14)
- FONAR Reports 12 Straight Quarters of Net Income From Operations and Six Straight Quarters of Profitability Greater Than $1.5 Million in 2nd Quarter Financial ResultsMarketwired(Thu, Feb 14)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.89 |
|---|
| Ex-Dividend Date: | 18-Mar-99 |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Fonar Corporation engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) medical scanning equipment for the detection and diagnosis of human diseases.
View More